SVB Leerink analyst Joseph Schwartz maintains Insmed (NASDAQ:INSM) with a Outperform and lowers the price target from $52 to $50.
Monaghan Medical And Premier Inc. Sign 3-Year Agreement To Provide Respiratory Devices To Clinicians, Effective May 1, 2023
Monaghan Medical Corporation (Monaghan) and Premier, Inc., today announced their agreement to a three-year contract, effective May 1, 2023, creating a partnership between two healthcare industry leaders. Under the terms
